RBC Capital, on February 25, reduced its target price on Fidelity National Information Services by 19.8% to $69 (from $86) but retained the firm’s Outperform call on the stock...
Keep Reading →
March 2 - News
Wells Fargo, on February 25, trimmed its target price on Equitable Holdings by 5.0% to $57 (from $60) but retained its Overweight call on the stock.
Keep Reading →
March 2 - News
Sitel, on February 23, trimmed its target price on DNOW by 11.1% to $16 (from $18), while retaining its Buy recommendation on the stock.
Keep Reading →
March 2 - News
KBR released its Q4 2025 earnings on February 26, which were headlined by a 10% YoY increase in adjusted diluted earnings per share, beating the street consensus estimate of $...
Keep Reading →
March 2 - News
Crescent Energy, on February 25, released its Q4 2025 earnings.
Keep Reading →
March 2 - News
Wells Fargo upgraded its call on Lincoln National to Overweight (from Equal Weight) on February 25.
Keep Reading →
March 2 - News
Stephens, on February 19, trimmed its target price on Sonic Automotive by 1.5% and retained its Equal Weight call on the stock.
Keep Reading →
March 2 - News
Cullen Capital Management, LLC, operating under the name Schafer Cullen Capital Management, Inc. (SCCM), has released its “SCCM Enhanced Equity Income Fund” fourth-quarter...
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Cullen Capital Management, LLC, operating under the name Schafer Cullen Capital Management, Inc. (SCCM), has released its “SCCM Enhanced Equity Income Fund” fourth-quarter...
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Cullen Capital Management, LLC, operating under the name Schafer Cullen Capital Management, Inc. (SCCM), has released its “SCCM Enhanced Equity Income Fund” fourth-quarter...
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Regulation is changing how lead generation works in industries where each customer can be worth a lot.
Keep Reading →
March 2 - Business, News
Cullen Capital Management, LLC, operating under the name Schafer Cullen Capital Management, Inc.
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Crossroads Capital LLC, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Crossroads Capital LLC, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Crossroads Capital LLC, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Crossroads Capital LLC, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Crossroads Capital LLC, an investment management company, released its fourth-quarter 2025 investor letter.
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Optimist Fund, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Optimist Fund, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Optimist Fund, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Optimist Fund, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Operator: Good morning, and welcome to the Wave Life Sciences Fourth Quarter and Full Year 2025 Earnings Conference Call.
Keep Reading →
March 2 - News, Transcripts
Operator: Welcome to the Opera Limited Fourth Quarter and Full Year 2025 Earnings Call. [Operator Instructions] Please be advised that today's call is being recorded.
Keep Reading →
March 2 - News, Transcripts
“I think the economic outlook is actually good,” according to Roger Altman, founder and senior chairman of Evercore, during an interview on CNBC’s Squawk Box on February...
Keep Reading →
March 2 - Hedge Funds, News
The S&P 500, the most widely used indicator of the US stock market, is difficult to beat.
Keep Reading →
March 2 - Hedge Funds, News
Invesco Ltd's “Small Cap Value Fund” released its Q4 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
March 2 - Hedge Fund Investor Letters, News
Gold stocks have been on a tear over the past year, with the precious metal smashing records on its way to record highs.
Keep Reading →
March 2 - Hedge Funds, News
AbbVie (NYSE:ABBV) is one of the best cancer stocks to invest in now.
Keep Reading →
March 2 - News
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the best cancer stocks to invest in now. On February 26, Revolution Medicines, Inc. (NASDAQ:RVMD) CEO Mark A.
Keep Reading →
March 2 - News
Arvinas Inc. (NASDAQ:ARVN) is one of the best cancer stocks to invest in now. On February 24, Arvinas Inc.
Keep Reading →
March 2 - News
Guardant Health Inc. (NASDAQ:GH) is one of the best cancer stocks to invest in now. On February 23, Guardant Health Inc.
Keep Reading →
March 2 - News
Cogent Biosciences Inc. (NASDAQ:COGT) is one of the best cancer stocks to invest in now. On February 17, CEO Andrew Robbins reiterated that Cogent Biosciences Inc.
Keep Reading →
March 2 - News
Immunome, Inc. (NASDAQ:IMNM) is one of the best cancer stocks to invest in now. On February 14, Immunome, Inc.
Keep Reading →
March 2 - News
Syndax Pharmaceuticals (NASDAQ:SNDX) is one of the best cancer stocks to invest in now.
Keep Reading →
March 2 - News
Schrodinger Inc. (NASDAQ:SDGR) is one of the best cancer stocks to invest in now. On February 25, Schrodinger Inc.
Keep Reading →
March 2 - News
Nuvation Bio Inc. (NYSE:NUVB) is one of the best cancer stocks to invest in now. On February 9, Nuvation Bio Inc.
Keep Reading →
March 2 - News
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best cancer stocks to invest in now. On February 23, Summit Therapeutics Inc.
Keep Reading →
March 2 - News
Janux Therapeutics Inc. (NASDAQ: JANX) is one of the best cancer stocks to invest in now. On February 17, Janux Therapeutics Inc.
Keep Reading →
March 2 - News
In an insider activity on February 4, 2026, East West Bancorp, Inc. (NASDAQ:EWBC) saw significant sales from one of its top executives.
Keep Reading →
March 1 - News
On February 25, 2026, Pravati Capital, one of the oldest litigation finance firms in the U.S., announced a strategic partnership with SEI Investments Company (NASDAQ:SEIC) to ...
Keep Reading →
March 1 - News
On February 25, 2026, Wells Fargo analyst Elyse Greenspan raised the price target on Globe Life Inc.
Keep Reading →
March 1 - News
On February 25, 2026, Bank of America downgraded its rating on Fox Corporation (NASDAQ:FOX) from Buy to Underperform and cut the price target from $80 to $45.
Keep Reading →
March 1 - News
On February 16, 2026, Cognizant Technology Solutions Corporation (NASDAQ:CTSH) announced its partnership with Google Cloud to scale agentic AI for enterprises.
Keep Reading →
March 1 - News
On February 26, 2026, KeyBanc raised its price target on Zoom Communications, Inc. (NASDAQ:ZM) from $69 to $74 while maintaining an Underweight rating.
Keep Reading →
March 1 - News
On February 26, 2026, The Travelers Companies, Inc.
Keep Reading →
March 1 - News
On February 26, 2026, H.C. Wainwright raised the price target on United Therapeutics Corporation (NASDAQ:UTHR) from $525 to $600 while maintaining a Buy rating.
Keep Reading →
March 1 - News
On February 27, 2026, Newmont Corporation (NYSE:NEM) saw its rating from Bernstein upgraded from Market Perform to Outperform.
Keep Reading →
March 1 - News
On February 17, 2026, Barclays analyst Benjamin Budish reiterated a Buy rating on The Charles Schwab Corporation (NYSE:SCHW) and kept a price target of $120.
Keep Reading →
March 1 - News
Truist raised its price target on BILL Holdings, Inc. (NYSE:BILL) from $58 to $59 and keeps a Buy rating on the stock, on February 10, 2026.
Keep Reading →
March 1 - News
On February 20, 2026, Wells Fargo analyst Christopher Carey maintained a Hold rating on PepsiCo, Inc. (NASDAQ:PEP) with a price target of $165.
Keep Reading →
March 1 - News
Hedge Fund Resource Center 
